Thomas Wallace, MD
Clinical Cardiac Electrophysiology · Little Rock, ARNPI 1295807733
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Biosense Webster, Inc. at 52.3% of the total. Reporting peaked in 2020 at $4,321 and has fallen 85.1% since, to $642 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in AR, where the typical reported total is $22,678.
Across 218 payments — averaging $63.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biosense Webster, Inc.$7K
- Medtronic$2K
- Abbott$973
- Medical Device Business Services, Inc.$923
- Novartis$675
- Boston Scientific$291
- plus $1K from 21 others
Across 63 payments — averaging $1613.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$42K
- Medical Device Business Services, Inc.$32K
- Medtronic$27K
What the payments were for
- Consulting fees$6,30046%
- Travel & lodging$2,14216%
- Food & beverage$5,24938%
- Education$861%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biosense Webster, Inc. | 32 | $7,204 |
| Medtronic(2 entities) | 32 | $2,221 |
| Abbott | 15 | $973 |
| Medical Device Business Services, Inc. | 3 | $923 |
| Novartis | 53 | $675 |
| Boston Scientific | 12 | $291 |
| Atricure, Inc. | 3 | $281 |
| E.r. Squibb & Sons, L.L.C. | 12 | $188 |
| Altathera Pharmaceuticals LLC | 1 | $145 |
| Sanofi-aventis U.S. LLC | 7 | $99 |
| Johnson & Johnson | 5 | $81 |
| Irhythm Technologies, Inc. | 5 | $81 |
| Pfizer | 4 | $71 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $61 |
| Amgen | 4 | $61 |
| Cordis US CORP. | 1 | $59 |
| Elutia, Inc. | 4 | $53 |
| United Therapeutics Corporation | 3 | $46 |
| Philips North America LLC | 3 | $44 |
| Boehringer Ingelheim | 3 | $39 |
| Shockwave Medical, Inc | 1 | $37 |
| Alnylam Pharmaceuticals Inc. | 2 | $32 |
| Cvrx, Inc. | 1 | $30 |
| AstraZeneca | 2 | $26 |
| Baxter Healthcare | 1 | $22 |
| Cardiva Medical, Inc. | 1 | $21 |
| Cardiovascular Systems Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3 System$5,030
- Carto 3$2,402
- Micra$520
- ENSITE$273
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$256
- AVEIR$172
- Sotalol Hydrochloride$145
How this compares
$13,777 in reported general payments places this provider in the 35th percentile of 25 clinical cardiac electrophysiology providers in Arkansas.
See all clinical cardiac electrophysiology providers in Arkansas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 1,576 | $1,135,615 |
| MultaqDronedarone Hcl | 224 | $213,189 |
| XareltoRivaroxaban | 225 | $177,319 |
| EntrestoSacubitril/Valsartan | 122 | $85,069 |
| Dofetilide | 71 | $13,271 |
| Metoprolol Succinate | 856 | $11,935 |
| Propafenone Hcl ErPropafenone Hcl | 39 | $8,317 |
| Amiodarone Hcl | 373 | $8,163 |
| Diltiazem 12hr ErDiltiazem Hcl | 16 | $5,829 |
| Propafenone Hcl | 134 | $5,229 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 33 | $4,131 |
| Digoxin | 185 | $3,155 |
| Carvedilol | 571 | $2,980 |
| Metoprolol Tartrate | 529 | $2,611 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 67 | $2,510 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $71 | $1,135,6151,576 claims |
| Sanofi-aventis U.S. LLCMultaq | $99 | $213,189224 claims |
| Johnson & JohnsonXarelto | $81 | $177,319225 claims |
| NovartisEntresto | $675 | $85,069122 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 25 clinical cardiac electrophysiology providers in Arkansas.
Other clinical cardiac electrophysiology in Little Rock
- Monica LoLittle Rock$190K
- Sudarone ThihalolipavanLittle Rock$77K
- Prabhat HebbarLittle Rock$75K
- Gerald GreerLittle Rock$41K
- Risheek KaulLittle Rock$38K
- Michael LoguidiceLittle Rock$29K
- Breck SandvallLittle Rock$23K
- Brian NorrisLittle Rock$18K
- Subodh DevabhaktuniLittle Rock$9K
- van de BruynLittle Rock$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.